论文部分内容阅读
老年人是2型糖尿病的主要患病人群,由于老年人身体的特殊性,比如肥胖、肝肾功能减退、合并心血管病多、好发低血糖等,因此,老年糖尿病降糖药物的选择需要能够兼顾上述情况,以便更加平稳地降低血糖,减少心血管并发症和降低不良反应发生率。为此,医学专家在种类繁多的降糖药中筛选出了二甲双胍,作为老年糖尿病的首选、初始降糖药,也作为联合应用中的基础用药。
Elderly people are the main type 2 diabetes patients, due to the special nature of the elderly, such as obesity, liver and kidney dysfunction, combined with cardiovascular disease, predisposing hypoglycemia, therefore, elderly diabetic hypoglycemic choice Can take into account the above situation, in order to more smoothly lower blood sugar, reduce cardiovascular complications and reduce the incidence of adverse reactions. To this end, medical experts in a wide variety of hypoglycemic agents selected out of metformin, as the first choice for elderly diabetes, the initial hypoglycemic agents, but also as a combination of the basic application.